Physician profile
Gyan Pareek
NPI 1376654350
$82,763.23
in general payments reported to CMS, 2019-2025
28 companies · $8,114 in 2025
The $8,114 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $7,061 · 2021: $14K · 2022: $4,068 · 2023: $26K · 2024: $5,971 · 2025: $8,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Honoraria: $1,704 · Travel and Lodging: $1,240 · Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,208.82 |
| Honoraria | $1,704.00 |
| Travel and Lodging | $1,240.04 |
| Food and Beverage | $892.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $48,003.08 | 2019-2025 | Spaceoar System, General - Therapies, General - Kidney Stone Disease |
| Gyrus Acmi, INC. | $9,088.81 | 2020-2022 | |
| Ambu A/S | $8,482.82 | 2023-2024 | |
| Cook Incorporated | $7,284.00 | 2019 | |
| Northgate Technologies, INC. | $3,500.00 | 2021 | |
| Photocure INC | $2,500.00 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $897.57 | 2019-2024 | Bard Urinary Drainage Bag |
| Cook Medical LLC | $820.58 | 2019 | |
| Olympus Corporation of The Americas | $450.00 | 2021 | |
| Olympus Corporation | $450.00 | 2022 | |
| Teleflex LLC | $305.62 | 2022 | |
| Ambu INC. | $188.63 | 2024-2025 | |
| Immunitybio, INC. | $173.67 | 2025 | |
| Astellas Pharma US INC | $149.36 | 2019-2021 | |
| Richard Wolf Medical Instruments Corp. | $74.45 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $70.92 | 2019 | |
| Abbvie INC. | $57.86 | 2019 | |
| Ferring Pharmaceuticals INC. | $37.26 | 2019 | |
| Blue Earth Diagnostics | $36.22 | 2019 | |
| Neotract INC. | $27.87 | 2019 | |
| Dendreon Pharmaceuticals LLC | $26.77 | 2019 | |
| Ethicon INC. | $25.21 | 2021 | |
| Allergan, INC. | $23.06 | 2019 | |
| Olympus America INC. | $20.70 | 2019 | |
| Osiris Therapeutics INC. | $20.69 | 2019 | |
| 180 Medical, INC. | $18.84 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.01 | 2019 | |
| Rochester Medical Corporation | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gyan Pareek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.